Ranibizumab for age-related macular degeneration

N Engl J Med. 2011 Feb 10;364(6):581-2. doi: 10.1056/NEJMc1013316.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / adverse effects
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Cardiovascular Diseases / mortality*
  • Humans
  • Injections, Intraocular
  • Ranibizumab
  • Risk Factors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Wet Macular Degeneration / drug therapy*
  • Wet Macular Degeneration / prevention & control

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Ranibizumab